SolicitationPosted Oct 19, 2026·Responses due Oct 29, 2026

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Defense Health Agency · ARMY MED RES ACQ ACTIVITY

Stage
Open solicitation
NAICS
325413
Value
Not stated
Solicitation
HT942627QE003
Set-aside
Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14)
PSC
6515
Place
JBSA Ft Sam Houston, TX, USA
Contact
Jeremy McMurry (jeremy.l.mcmurry.civ@health.mil)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT942627QE003 in this department, oldest first.

Early notice
None posted
Solicitation
  • Oct 19, 2026 · this notice
    Solicitation
  • Oct 19, 2026
    Solicitation
    Open
Award
Not yet. Typical award: Nov 10, 2026 to Dec 29, 2026, middle of the range Nov 25, 2026.
Measured from 63 past solicitations at Defense Health Agency (Dha) that later posted an award (middle half of cases, counted from Oct 19, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

USAISR's Combat Casualty Care Research Team 1 (CRT-1) requires resupply of its Blood Donor Room on a reoccurring basis in order to satisfy research requirements for blood collection. USAISR currently has three Terumo Trima Accel Blood Collection Systems in operation. These units support numerous research protocols. Various collection sets are used to collect a variety of blood products from donors. The Trima instrument is FDA-approved, but only with the use of original manufacturer-supplied consumable products. These consumables are specific to the instrument and there are no generic substitut… (show all)

e products available in the marketplace. Please note - This is a 100% ser-aside for Service-Disabled Veteran-Owned Small Businesses. See attached complete solicitation for all requirement details and instructions to offerors.

Who won similar work

55 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Defense Health Agency), same product/service code (PSC) 6515.

Single-winner award sizes (55): middle half $36K to $121K, median $62K; range $14K to $1.3M.

WinnerAwardsValueLast
STERIS CORPORATION · $STE · $6.0B3$351KSep 10, 2026
Trillamed LLC2$172KSep 28, 2026
NIHON KOHDEN AMERICA, LLC2$148KAug 24, 2026
GLOBUS MEDICAL, INC. · $GMED · $3.1B2$126KFeb 23, 2026
AB MARTIN SERVICES INC2$111KSep 10, 2026
FENWAL, INC.2$104KSep 18, 2026
O R ELDER INC2$64KAug 11, 2026
PHADIA US INC · $TMO · $46.3B1$1.3MJul 17, 2026
THE MACLEAN GROUP LLC1$1.0MApr 9, 2026
SDV OFFICE SYSTEMS LLC1$675KFeb 26, 2025

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Investor context
  • $STE reported $6.0B revenue (12 months to Jun 30, 2026). The median single-winner award in these 55 past awards, $62K, is under 0.1% of that. SEC filing
  • $GMED reported $3.1B revenue (12 months to Jun 30, 2026). The median single-winner award in these 55 past awards, $62K, is under 0.1% of that. SEC filing
  • $TMO reported $46.3B revenue (12 months to Jun 27, 2026). The median single-winner award in these 55 past awards, $62K, is under 0.1% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (2 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • $60K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 3 of the past winners are listed companies
  • 0 insider buys and 8 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.